Literature DB >> 12525655

The promyelocytic leukemia protein does not mediate foamy virus latency in vitro.

Christopher D Meiering1, Maxine L Linial.   

Abstract

Spumaviruses, commonly called foamy viruses, are complex retroviruses that establish life-long persistent infections in the absence of accompanying pathology. Depending upon cell type, infection of cells in tissue culture cells can result in either lytic replication, persistence, or latency. The cellular factors that mediate foamy virus (FV) latency are poorly understood. In this study we show that the only known inhibitor of FV replication, the promyelocytic leukemia protein (PML), which binds the FV transactivator (Tas), does not play an important role in FV latency in vitro. We found no significant differences in PML levels in cells that supported lytic replication compared to those that were latently infected. Furthermore, endogenous PML levels did not change following exposure to phorbol myristate acetate (PMA), which induces FV replication. We demonstrated that FV replication proceeded in the presence of substantial levels of PML, both in fully permissive cells and during reactivation of latent FV. Endogenous PML did not efficiently colocalize with Tas, even after upregulation by alpha interferon (IFN-alpha) treatment. IFN-alpha did, however, partially suppress the reactivation of latent FV by PMA. Finally, depletion of endogenous PML by small interfering RNA did not promote activation of FV in cells that responded to PMA treatment. Taken together, these data indicate that endogenous PML does not play an important role in mediating FV latency.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12525655      PMCID: PMC140967          DOI: 10.1128/jvi.77.3.2207-2213.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding.

Authors:  J E Garrus; U K von Schwedler; O W Pornillos; S G Morham; K H Zavitz; H E Wang; D A Wettstein; K M Stray; M Côté; R L Rich; D G Myszka; W I Sundquist
Journal:  Cell       Date:  2001-10-05       Impact factor: 41.582

2.  PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator.

Authors:  T Regad; A Saib; V Lallemand-Breitenbach; P P Pandolfi; H de Thé; M K Chelbi-Alix
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

3.  Simian foamy virus-induced immunosuppression in rabbits.

Authors:  J J Hooks; B Detrick-Hooks
Journal:  J Gen Virol       Date:  1979-08       Impact factor: 3.891

4.  Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia.

Authors:  A D Goddard; J Borrow; P S Freemont; E Solomon
Journal:  Science       Date:  1991-11-29       Impact factor: 47.728

5.  Reactivation of a complex retrovirus is controlled by a molecular switch and is inhibited by a viral protein.

Authors:  Christopher D Meiering; Maxine L Linial
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-01       Impact factor: 11.205

Review 6.  Review: properties and assembly mechanisms of ND10, PML bodies, or PODs.

Authors:  G G Maul; D Negorev; P Bell; A M Ishov
Journal:  J Struct Biol       Date:  2000-04       Impact factor: 2.867

7.  Cell-type-specific regulation of the two foamy virus promoters.

Authors:  C D Meiering; C Rubio; C May; M L Linial
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

8.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

Review 9.  DNA viruses and viral proteins that interact with PML nuclear bodies.

Authors:  R D Everett
Journal:  Oncogene       Date:  2001-10-29       Impact factor: 9.867

Review 10.  PML interaction with p53 and its role in apoptosis and replicative senescence.

Authors:  M Pearson; P G Pelicci
Journal:  Oncogene       Date:  2001-10-29       Impact factor: 9.867

View more
  7 in total

1.  Restriction of foamy viruses by primate Trim5alpha.

Authors:  Melvyn W Yap; Dirk Lindemann; Nicole Stanke; Juliane Reh; Dana Westphal; Helmut Hanenberg; Sadayuki Ohkura; Jonathan P Stoye
Journal:  J Virol       Date:  2008-03-26       Impact factor: 5.103

2.  IFP35 is involved in the antiviral function of interferon by association with the viral tas transactivator of bovine foamy virus.

Authors:  Juan Tan; Wentao Qiao; Jian Wang; Fengwen Xu; Yue Li; Jun Zhou; Qimin Chen; Yunqi Geng
Journal:  J Virol       Date:  2008-02-27       Impact factor: 5.103

Review 3.  Bovine Foamy Virus: Shared and Unique Molecular Features In Vitro and In Vivo.

Authors:  Magdalena Materniak-Kornas; Juan Tan; Anke Heit-Mondrzyk; Agnes Hotz-Wagenblatt; Martin Löchelt
Journal:  Viruses       Date:  2019-11-21       Impact factor: 5.048

Review 4.  Retroviral superinfection resistance.

Authors:  Micha Nethe; Ben Berkhout; Antoinette C van der Kuyl
Journal:  Retrovirology       Date:  2005-08-18       Impact factor: 4.602

Review 5.  Early events in foamy virus-host interaction and intracellular trafficking.

Authors:  Ursula Berka; Martin Volker Hamann; Dirk Lindemann
Journal:  Viruses       Date:  2013-04-08       Impact factor: 5.048

Review 6.  Interplay between RNA Viruses and Promyelocytic Leukemia Nuclear Bodies.

Authors:  Sabari Nath Neerukonda
Journal:  Vet Sci       Date:  2021-03-31

Review 7.  Foamy Viruses, Bet, and APOBEC3 Restriction.

Authors:  Ananda Ayyappan Jaguva Vasudevan; Daniel Becker; Tom Luedde; Holger Gohlke; Carsten Münk
Journal:  Viruses       Date:  2021-03-18       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.